ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although in about 95% of all CML cases, the gold standard for diagnosis and followup is conventional cytogenetics, the other 5%, including variant translocations, cryptic BCR-ABL rearrangements or masked Ph, are only detectable by molecular cytogenetics (5, 8, 10-12).